RESUMO
Mammalian adrenodoxin (Adx) has been known for many years as an essential electron mediator in mitochondrial cytochrome P450 systems. Because of its ability to support several cytochrome P450 enzymes, it is involved not only in adrenal steroid hormone biosynthesis but also in vitamin D and bile acid metabolism. Recently, Adx is increasingly gaining attention because of its potential for pharmaceutical industry and biotechnology. With human cytochromes P450 becoming important drug targets, suitable Adx-based screening systems have to be developed to test putative new drugs. Moreover, in artificial systems, Adx has been shown to functionally interact with diverse bacterial cytochromes P450 catalyzing a variety of chemically interesting reactions. Putative biotechnological applications of such Adx-containing reconstituted systems are discussed.
Assuntos
Adrenodoxina/fisiologia , Ferredoxinas/fisiologia , Adrenodoxina/biossíntese , Adrenodoxina/química , Animais , Proteínas de Bactérias/química , Proteínas de Bactérias/fisiologia , Coenzimas/biossíntese , Sistema Enzimático do Citocromo P-450/química , Sistema Enzimático do Citocromo P-450/fisiologia , Avaliação Pré-Clínica de Medicamentos , Ferredoxinas/biossíntese , Ferredoxinas/química , Humanos , Mitocôndrias/enzimologia , Oxirredução , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/químicaRESUMO
Mitochondrial cytochrome P450 systems are an indispensable component of mammalian steroid biosynthesis; they catalyze regio- and stereo-specific steroid hydroxylations and consist of three protein entities: adrenodoxin reductase (AdR), adrenodoxin (Adx), and a mitochondrial cytochrome P450 enzyme, e.g., CYP11A1 (P450 side chain cleavage, P450scc). It is known that the latter two are able to generate reactive oxygen species (ROS) in vitro . In this study, we investigated whether this ROS generation also occurs in vivo and, if so, whether it leads to the induction of apoptosis. We found that overexpression of either human or bovine Adx causes a significant loss of viability in 11 different cell lines. This loss of viability does not depend on the presence of the tumor suppressor protein p53. Transient overexpression of human Adx in HCT116 cells leads to ROS production, to a disruption of the mitochondrial transmembrane potential (DeltaPsi), to cytochrome c release from the mitochondria, and to caspase activation. In contrast, the effect of transient overexpression of human CYP11A1 on cell viability varies in different cell lines, with some being sensitive and others not. We conclude that mitochondrial cytochrome P450 systems are a source of mitochondrial ROS production and can play a role in the induction of mitochondrial apoptosis.
Assuntos
Adrenodoxina/fisiologia , Apoptose , Enzima de Clivagem da Cadeia Lateral do Colesterol/fisiologia , Mitocôndrias/fisiologia , Espécies Reativas de Oxigênio/metabolismo , Adrenodoxina/biossíntese , Animais , Caspases/metabolismo , Bovinos , Linhagem Celular , Sobrevivência Celular , Enzima de Clivagem da Cadeia Lateral do Colesterol/biossíntese , Citocromos c/metabolismo , Ativação Enzimática , Humanos , Potenciais da Membrana , Mitocôndrias/metabolismo , Ativação Transcricional , Proteína Supressora de Tumor p53/metabolismoRESUMO
The interactions of CYP11B1 (cytochrome P-45011beta), CYP11B2 (cytochrome P-450aldo) and CYP11A1 (cytochrome P-450scc) were investigated by cotransfection of their cDNA into COS-1 cells. The effect of CYP11A1 on CYP11B isozymes was examined by studying the conversion of 11-deoxycorticosterone to corticosterone, 18-hydroxycorticosterone and aldosterone. It was shown that when human or bovine CYP11B1 and CYP11A1 were cotransfected they competed for the reducing equivalents from the limiting source contained in COS-1 cells; this resulted in a decrease of the CYP11B activities without changes in the product formation patterns. The competition of human CYP11A1 with human CYP11B1 and CYP11B2 could be diminished with excess expression of bovine adrenodoxin. However, the coexpression of bovine CYP11B1 and CYP11A1 in the presence of adrenodoxin resulted in a stimulation of 11beta-hydroxylation activity of CYP11B1 and in a decrease of the 18-hydroxycorticosterone and aldosterone formation. These results suggest that the interactions of CYP11A1 with CYP11B1 and CYP11B2 do not have an identical regulatory function in human and in bovine adrenal tissue.
Assuntos
Células COS/enzimologia , Enzima de Clivagem da Cadeia Lateral do Colesterol/metabolismo , Esteroide 11-beta-Hidroxilase/metabolismo , Adrenodoxina/biossíntese , Adrenodoxina/metabolismo , Adrenodoxina/fisiologia , Aldosterona/biossíntese , Animais , Bovinos , Chlorocebus aethiops , Enzima de Clivagem da Cadeia Lateral do Colesterol/fisiologia , Ativação Enzimática , Humanos , Hidroxilação , Isoenzimas/antagonistas & inibidores , Isoenzimas/metabolismo , Oxigenases de Função Mista/metabolismo , Esteroide 11-beta-Hidroxilase/antagonistas & inibidores , Esteroide 11-beta-Hidroxilase/fisiologiaRESUMO
The three-dimensional structure of a truncated mutant of bovine adrenodoxin has been resolved at 1.85 A resolution by MAD. The protein consists of a large core region and a more flexible hairpin loop bearing residues which have been previously described as being involved in redox partner recognition. To study the role of distinct protein domains and amino acids of adrenodoxin in interaction with adrenodoxin reductase (AdR), CYP11A1 and CYP11B1, as well as in electron transfer, mutants of adrenodoxin have been prepared by site-directed mutagenesis and produced in Escherichia coli, and their structural and functional properties have been characterized in detail. It could be demonstrated that Tyr82 is located at the edge of the flexible interaction loop of adrenodoxin participating in interactions with AdR and P450s. His56, being close to Tyr82, forms a bridge between the core region of adrenodoxin and the interaction loop. Its role in transmitting changes of the cluster region to the interaction site has also been supported by functional studies. Pro108 of adrenodoxin, the only proline residue contained in the protein and being conserved in this position among several other vertebrate-type ferredoxins, has been demonstrated to be of importance for the correct folding of this protein.
Assuntos
Adrenodoxina/química , Adrenodoxina/fisiologia , Mitocôndrias/metabolismo , Esteroides/metabolismo , Adrenodoxina/genética , Sequência de Aminoácidos/genética , Animais , Bovinos , Enzima de Clivagem da Cadeia Lateral do Colesterol/metabolismo , Transporte de Elétrons/fisiologia , Ferredoxina-NADP Redutase/metabolismo , Ferredoxinas/química , Ferredoxinas/genética , Hidroxilação , Conformação Molecular , Mutação/genética , Esteroide 11-beta-Hidroxilase/metabolismoRESUMO
Selective chemical modification of cytochrome P-450SCC has been carried out with lysine-modifying reagents. Modification of cytochrome P-450SCC with succinic anhydride was shown to result in loss of its ability to interact with intermediate electron transfer protein - adrenodoxin. To identify amino acid residues involved in charge-ion pairing with complementary carboxyl groups of adrenodoxin, cytochrome P-450SCC complex with adrenodoxin was modified with succinic anhydride. Adrenodoxin was then removed and cytochrome P-450 was additionally modified with isotopically labelled reagent. Subsequent chymotryptic hydrolysis of [14C]succinylated cytochrome P-450SCC and separation of digest obtained by combining various types of HPLC resulted in seven major radioactive peptides. The amino acid sequence of the peptides was determined by microsequencing. The major amino groups modified with radioactive succinic anhydride were found to be at Lys-73, -109, -110, -126, -145, -148 and -154 in the N-terminal sequence of cytochrome P-450SCC molecule and at Lys-267, -270, -338 and -342 in the C-terminal sequence. The role of electrostatic interactions in fixation of cytochrome P-450SCC complex with adrenodoxin is discussed.